Fight for the education of the Aymara communities of Puno (Peru)

The article refers to the historical process of struggle for education undertaken by the Aymara communities in the Puno region (Peru). The objective is to visualize the main facts and moments of vindication and identifies the challenges and hopes, which still demand at present. In the results, the struggle to read and write has been identified in the first place; second, the conquest of the school by the communities; and in the third part the impertinence of education or the decontextualization of the school is visualized. The methodology used was ethnography, exploring events in the struggle for the education of the communities, providing descriptive data about the media, contexts and the participants involved in the historical process. It has identified actors such as the State, the community and the school, and the main aspects, social, political, economic and environmental, linked to the daily activities of agriculture and livestock. Capitalism has understood education as a commodity. The challenges and hopes are the demand and the permanent struggle for an education of relevance and contextualized, which could be assumed by the State with equity and justice in educational policy decisions

Integrative systems medicine approaches to identify molecular targets in lymphoid malignancies

Although survival rates for lymphoproliferative disorders are steadily increasing both in the US and in Europe, there is need for optimizing front-line therapies and developing more effective salvage strategies. Recent advances in molecular genetics have highlighted the biological diversity of lymphoproliferative disorders. In particular, integrative approaches including whole genome sequencing, whole exome sequencing, and transcriptome or RNA sequencing have been instrumental to the identification of molecular targets for treatment. Herein, we will discuss how genomic, epigenomic and proteomic approaches in lymphoproliferative disorders have supported the discovery of molecular lesions and their therapeutic targeting in the clinic